சுருக்கம்

Simultaneous Determination of Telmisartan and Amlodipine Besylate in Tablet Dosage form by Spectrophotometry S. Angayer Kanchana, Ajithadas Aruna, V. Niraimathi and A. Jerad SureshSimultaneous Determination of Telmisartan and Amlodipine Besylate in Tablet Dosage form by Spectrophotometry

S. Angayer Kanchana, Ajithadas Aruna, V. Niraimathi and A. Jerad Suresh


Two new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and amlodipine in pharmaceutical dosage form. The methods employed were absorbance correction method (Method A) and dual wavelength method (Method B). The method A employs wavelength 350.4 nm for direct estimation of amlodipine where telmisartan shows nil absorbance. Estimation of telmisartan is carried out after correction for absorbance of telmisartan at 239 nm. In method B, amlodipine was determined by plotting the difference in absorbance at 247.4 and 299 nm (difference is zero for telmisartan) against the concentration of amlodipine. Similarly, for the determination of telmisartan, the difference in absorbance at 226 and 248 nm (difference is zero for amlodipine) was plotted against the concentration of telmisartan. Both the drugs obey the Beer’s law in the range 5-50µg/mL for amlodipine at 239 nm and 5-40 µg/mL at 350.4 nm and 5-35 µg/mL for telmisartan at 239 for Method A, and 5-50 µg/mL for amlodipine and 5-30 µg/mL for telmisartan for Method B. The results of analysis have been validated statistically and by recovery studies.


குறியிடப்பட்டது

  • CASS
  • கூகுள் ஸ்காலர்
  • ஜே கேட் திறக்கவும்
  • சீனாவின் தேசிய அறிவு உள்கட்டமைப்பு (CNKI)
  • CiteFactor
  • காஸ்மோஸ் IF
  • எலக்ட்ரானிக் ஜர்னல்ஸ் லைப்ரரி
  • டைரக்டரி ஆஃப் ரிசர்ச் ஜர்னல் இன்டெக்சிங் (DRJI)
  • ரகசிய தேடுபொறி ஆய்வகங்கள்
  • ICMJE

மேலும் பார்க்க

ஜர்னல் எச்-இண்டெக்ஸ்

Flyer